Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Grade</td><td class="align_center">Percentage of the occupied changed tissue slice surface</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">0</td><td class="align_center">0</td></tr><tr><td class="align_left">1</td><td class="align_center">1-25%</td></tr><tr><td class="align_left">2</td><td class="align_center">26-50%</td></tr><tr><td class="align_left">3</td><td class="align_center">51-75%</td></tr><tr><td class="align_left">4</td><td class="align_center">76-100%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The semiquantitative scale implemented for the assessment of the articular cartilage and synovial membrane degree of lesions in analyzed tissue slices per HPF.</div>

Journal of Immunology Research

tab1

Table 1

Table 1: Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis 

Table 1 | Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis 